CONSTRUCTION AND CHARACTERIZATION OF AN ACTIVE FACTOR-VIII VARIANT LACKING THE CENTRAL 1/3 OF THE MOLECULE

被引:265
作者
EATON, DL
WOOD, WI
EATON, D
HASS, PE
HOLLINGSHEAD, P
WION, K
MATHER, J
LAWN, RM
VEHAR, GA
GORMAN, C
机构
关键词
D O I
10.1021/bi00374a001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The primary structure of factor VIII consists of 2332 amino acids that exhibit 3 distinct structural domains, including a triplicated region (A domains), a unique region of 909 amino acids (B domain), and a carboxy-terminal duplicated region (C domains), that are arranged in the order A1-A2-B-A3-C1-C2. The B domain (residues 741-1648) of factor VIII is lost when factor VIII is activated by thrombin, which proteolytically processes factor VIII to active subunits of Mr 50 000 (domain A1), 43 000 (domain A2), and 73 000 (domains A3-C1-C2). To determine if the B domain is required for factor VIII coagulant activity, a variant was constructed by using recombinant DNA techniques in which residues 797-1562 were eliminated. This shortened the B domain from 909 to 142 amino acids. This variant factor VIIIdes-797-1652 was expressed in mammalian cells and was found to be functional. The factor VIIIdes-797-1562 protein was purified and shown to be processed by thrombin in the same manner as full-length factor VIII. The factor VIIIdes-797-1562 variant also bound to von Willebrand factor (vWF) immobilized on Sepharose. These results indicate that most of the highly glycosylated B domain of factor VIII is not required for the expression of factor CIII coagulant activity and its interaction with vWF.
引用
收藏
页码:8343 / 8347
页数:5
相关论文
共 37 条
  • [1] A VERY STRONG ENHANCER IS LOCATED UPSTREAM OF AN IMMEDIATE EARLY GENE OF HUMAN CYTOMEGALO-VIRUS
    BOSHART, M
    WEBER, F
    JAHN, G
    DORSCHHASLER, K
    FLECKENSTEIN, B
    SCHAFFNER, W
    [J]. CELL, 1985, 41 (02) : 521 - 530
  • [2] HEAVY-CHAIN VARIABLE REGION CONTRIBUTION TO THE NPB FAMILY OF ANTIBODIES - SOMATIC MUTATION EVIDENT IN A GAMMA-2A VARIABLE REGION
    BOTHWELL, ALM
    PASKIND, M
    RETH, M
    IMANISHIKARI, T
    RAJEWSKY, K
    BALTIMORE, D
    [J]. CELL, 1981, 24 (03) : 625 - 637
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] PURIFIED HUMAN FACTOR-VIII PROCOAGULANT PROTEIN - COMPARATIVE HEMOSTATIC RESPONSE AFTER INFUSIONS INTO HEMOPHILIC AND VONWILLEBRAND DISEASE DOGS
    BRINKHOUS, KM
    SANDBERG, H
    GARRIS, JB
    MATTSSON, C
    PALM, M
    GRIGGS, T
    READ, MS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) : 8752 - 8756
  • [5] COAGULATION FACTOR-V AND FACTOR-VIII AND CERULOPLASMIN CONSTITUTE A FAMILY OF STRUCTURALLY RELATED PROTEINS
    CHURCH, WR
    JERNIGAN, RL
    TOOLE, J
    HEWICK, RM
    KNOPF, J
    KNUTSON, GJ
    NESHEIM, ME
    MANN, KG
    FASS, DN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (22): : 6934 - 6937
  • [6] PROTEOLYTIC PROCESSING OF HUMAN FACTOR-VIII - CORRELATION OF SPECIFIC CLEAVAGES BY THROMBIN, FACTOR XA, AND ACTIVATED PROTEIN-C WITH ACTIVATION AND INACTIVATION OF FACTOR-VIII COAGULANT ACTIVITY
    EATON, D
    RODRIGUEZ, H
    VEHAR, GA
    [J]. BIOCHEMISTRY, 1986, 25 (02) : 505 - 512
  • [7] EATON DL, 1986, J BIOL CHEM
  • [8] ESMON CT, 1979, J BIOL CHEM, V254, P964
  • [9] FASS DN, 1982, BLOOD, V59, P594
  • [10] THE SIZE OF HUMAN FACTOR-VIII HETERODIMERS AND THE EFFECTS PRODUCED BY THROMBIN
    FAY, PJ
    ANDERSON, MT
    CHAVIN, SI
    MARDER, VJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 871 (03) : 268 - 278